Filter
8149
Filtered Results: 8149
Text search:
update
Featured
Recommendations
788
New Publications
2085
Language
Document type
No document type
4147
Studies & Reports
1266
Guidelines
1178
Manuals
397
Strategic & Response Plan
308
Fact sheets
275
Situation Updates
238
Training Material
129
Resource Platforms
91
Infographics
63
Brochures
23
Online Courses
17
Videos
13
Dashboards/Maps
2
App
2
Countries / Regions
Global
325
India
278
Kenya
192
South Africa
180
Sierra Leone
169
Liberia
165
Western and Central Europe
154
Uganda
152
Myanmar / Burma
138
Nigeria
136
Nepal
136
Ethiopia
133
Latin America and the Carribbean
131
Bangladesh
115
Ukraine
112
Syria
107
Rwanda
104
Malawi
102
Africa
99
Congo, Democratic Republic of
94
Zambia
87
Tanzania
87
Ghana
76
Philippines
76
South Sudan
76
Guinea
72
Mozambique
64
Russia
64
Germany
60
Eastern Europe
59
Brazil
56
Venezuela
56
Yemen
55
Zimbabwe
54
Namibia
54
Haiti
53
Lesotho
50
West and Central Africa
50
East and Southern Africa
49
Indonesia
47
Middle East and North Africa
45
Colombia
44
Cambodia
42
South–East Asia Region
42
Senegal
40
Eastern Europe and Central Asia
40
Asia
36
Pakistan
31
Burkina Faso
30
Botswana
30
Argentina
28
Afghanistan
27
Central African Republic
26
Cameroon
24
Mali
21
Eswatini/ Swaziland
19
Sudan
18
Madagascar
18
USA
17
Benin
17
Vietnam
17
Côte d’Ivoire / Ivory Coast
16
Angola
16
Somalia
15
Lebanon
15
Peru
15
Paraguay
15
Jordan
14
Moldova
14
Thailand
13
Ecuador
13
Chile
13
Turkey
12
China
12
Western Pacific Region
12
Laos
12
Tajikistan
12
Niger
11
Iraq
10
Bolivia
10
Albania
10
Libya
9
United Kingdom
9
Singapore
8
Burundi
8
Palestine
8
Guinea-Bissau
7
Chad
7
Sri Lanka
7
Georgia
7
Gambia
6
Papua New Guinea
6
Greece
6
Bhutan
6
Italy
6
Southern Africa
6
Jamaica
6
Spain
6
Hungary
5
Poland
5
Romania
5
Iran
5
Kyrgyzstan
5
Kazakhstan
5
Togo
4
Egypt
4
North Macedonia
4
El Salvador
4
Mexico
4
Armenia
4
Congo-Brazzaville
4
Timor Leste/ East Timor
4
Uzbekistan
4
Turkmenistan
4
France
4
Tunisia
4
Portugal
4
Belarus
4
Malaysia
3
Serbia
3
Croatia
3
North America
3
Bosnia and Herzegovina
3
Saudi Arabia
2
Mauritania
2
Ireland
2
Vanuatu
2
Honduras
2
Guatemala
2
Nicaragua
2
Fiji
2
Djibouti
2
Canada
2
Bulgaria
2
Estonia
2
Slovakia
2
Australia
2
Uruguay
2
Mauritius
2
Morocco
1
Switzerland
1
Slovenia
1
Other region
1
Solomon Islands
1
North Korea
1
Mongolia
1
Qatar
1
Gabon
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
South Korea
1
Algeria
1
Morocco
1
Azerbaijan
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3023
Clinical Guidelines
630
Women & Child Health
406
Public Health
388
Key Resources
350
Capacity Building
140
Pharmacy & Technologies
76
Annual Report MEDBOX
3
Toolboxes
COVID-19
1163
HIV
624
Mental Health
479
TB
427
Rapid Response
313
Ebola
273
Planetary Health
272
Conflict
256
AMR
215
Caregiver
197
Disability
168
NTDs
162
Refugee
156
NCDs
153
Pharmacy
146
Natural Hazards
136
Global Health Education
114
Zika
108
Health Financing Toolbox
74
Polio
64
Cholera
58
Specific Hazards
40
Social Ethics
10
Typhoon
9
South Sudan
2
Health Financing
1
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
...d assay decontamination before disposal;
personal protective equipment (PPE) for specimen collection;
addressing chemical hazards and their safe disposal; and
the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4.
- Interim guide: May 2020 update.
On the 25th of March, the GPEI circulated the first update of the interim guide to help ensure continuity of the programme’s operations in the context of the COV...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
...d assay decontamination before disposal;
personal protective equipment (PPE) for specimen collection;
addressing chemical hazards and their safe disposal; and
the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4.
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
...d assay decontamination before disposal;
personal protective equipment (PPE) for specimen collection;
addressing chemical hazards and their safe disposal; and
the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4.
This document is an update of the guidance published on 21 March 2020 and contains new evidence and guidance.
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
2021 UNAIDS Global AIDS Update. UNAIDS report shows that people living with HIV face a double jeopardy, HIV and COVID-19, while key populations and children continue to be left behind in access to HIV services
COVID-19 Situation Update OPS/WHO Argentina: 10 February 2022
Situation report generated by the OPS/WHO representation in Argentina
WHO issued an updated appeal (May 2022) detailing its resource needs for Ukraine and refugee-receiving and hosting countries for March-August for Ukraine and March-December 2022 for other countries.
The needs are an estimated US$ 147.5 million: US$...
Europe and Central Asia Economic Update.
The Russian Federation’s war with Ukraine has triggered a catastrophic humanitarian crisis and threatened the stability of geopolitical relations. Economic output in the Europe and Central Asia region is f...
Technical document, update 2021
This guideline provides updated, evidence-informed guidance on the percentage of total fat in the diet to reduce the risk of unhealthy weight gain.
This guideline is intended for a wide audience involved in the development, design and implementat...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
...d risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) ...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. Th...
SODIS manual - updated version
The SODIS manual contains detailed information about technical and promotional aspects of the SODIS method.
Former version also available in French, Portuguese, Spanish, Uzbek, Russian
WHO Factsheet. Updated 02 March 2016
Fact sheet -Updated November 2015
This is an updated introductory two-page document that defines AIDS vaccines and reviews key developments in the field.
